What's in Nuvalent Inc.'s pipeline?

Nuvalent Inc. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Nuvalent Inc.'s portfolio?

Top competitors by shared drug class: ALK-Abelló A/S, ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA), Astellas Pharma Global Development, Inc., Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nuvalent-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Nuvalent Inc. — Portfolio Competitive Intelligence Brief

Nuvalent Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Neladalkib (NVL-655)	Neladalkib (NVL-655)	phase 3	ALK inhibitor	ALK (anaplastic lymphoma kinase)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ALK-Abelló A/S · 1 shared drug class
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 1 shared drug class
Astellas Pharma Global Development, Inc. · 1 shared drug class
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair · 1 shared drug class
Pfizer · 1 shared drug class
Takeda · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nuvalent Inc.:

Cite this brief

Drug Landscape (2026). Nuvalent Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nuvalent-inc. Accessed 2026-05-14.